| Project/Area Number |
21790798
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Kidney internal medicine
|
|---|
| Research Institution | The University of Tokyo |
|---|
Principal Investigator |
HORITA Shoko The University of Tokyo, 医学部附属病院, 特任助教 (20534895)
|
|---|
| Project Period (FY) |
2009 – 2010
|
| Project Status |
Completed (Fiscal Year 2010)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2010: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2009: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
|
|---|
| Keywords | 水 / 電解質代謝学 / チアゾリン / PPARγ / 糖尿病 / NHE1 / 近位尿細管 / 体液量 / 心腎相関 / シグナル伝達系 / 近位尿細管Na再吸収 / 種差 / Src / ERK |
|---|
| Research Abstract |
Thiazolinediones (TZDs), the medical drug used for the treatment of diabetes, have the side-effects of edema and congestive heart failure. We have investigated the mechanism of this side-effect by physiological studies and assays of proteins with culture cells and the kidneys of rats and mice. We found that TZDs enhance sodium reabsorption from renal proximal tubules via rapid signal transduction system, independently of transcription system. This may lead to develop new drugs for diabetes that do not have such side effects. (Cell Metabolism 13(5), pp.550-561, 2011)
|
